Bliss GVS Pharma Ltd approves unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026
- The Board met on October 29, 2026.
- Auditors’ limited review reports were also considered and approved.
Bliss GVS Pharma Board Meeting Highlights
This is an automated summary of a public document. Always check the original before relying on it.